We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Tocris Bioscience Extends Range of Light-Sensitive Caged Compounds Developed by Columbia University

News   Mar 10, 2010

 
Tocris Bioscience Extends Range of Light-Sensitive Caged Compounds Developed by Columbia University
 
 
 

RELATED ARTICLES

Identifying Alzheimer's Drug Candidates with Anti-aging Properties

News

Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.

READ MORE

Sequencing Offers New Hope for Rare Cancers

News

A cancer’s genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

READ MORE

He or She? Remains Tell the Whole Tooth

News

Researchers have come up with a new way to estimate the biological sex of human skeletal remains based on protein traces from teeth.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE